"Henan Provincial Medical Institutional Implementation Pharmaceutical Policy Expert Consensus" release (full text+download)

In January 2019, the General Office of the State Council issued the "Notice on Printing and Distributing the Pilot Plan for centralized procurement and use of national organizations" (National Office [2019] No. 2) [1], select 11 cities including Beijing, Tianjin The selection pilot varieties corresponding to the general names corresponding to the simulated drugs corresponding to the efficacy assessment, and carried out centralized procurement and use of drugs in the country (referred to as the collection of drugs). Pharmaceutical collection is an important measure to coordinate the reform of the supply side of pharmaceutical services. It has played an important role in improving the well -being of people's livelihood, promoting the three medical linkage, and promoting the healthy development of the pharmaceutical industry. At the end of 2019, the Henan Provincial Health and Health Commission and Henan Provincial Medical Security Bureau successively released a series of documents [2-4] to make arrangements for the comprehensive implementation of medical institutions in Henan Province. In 2021, the collection of pharmaceutical collection entered the stage of normalization and institutionalization [5], and provincial and regional alliances successively carried out different forms of provincial and regional alliance drugs to further expand the coverage of drugs.

As of May 31, 2022, Henan Province has implemented 6 batches of national organizational drug collection work, 1 batch of Henan Province organizational drug collection work, and 6 batches of drug collection work for regional alliance organizations, which has achieved good social and economic benefits Essence However, at present, because various medical institutions lack uniform and standardized standards for the management of drug management and the reasonable use of clinical clinical use, some medical institutions are facing many problems during the implementation process. Therefore, under the guidance of the Henan Provincial Pharmaceutical Management and Drug Therapy Committee, Henan Pharmaceutical Society organized experts in the province to write "Henan Medical Institutions Implementation of Pharmaceutical Policy Experts Consensus" to further promote the province's medical institutions to be more. Good implementation of drug collection policies, meet the needs of drugs for different patients, and provide reference for clinical reasonable medication.

1. Establish a special working group for collection of drugs

Medical institutions should set up special work groups in the collection of drugs in accordance with the actual situation. Medical insurance, medical, pharmacy, information, finance and other departments participated together to coordinate the development of drug collection.

2. Report quantity and task allocation

The purchase volume agreed in the collection of drugs is generally used by the pharmacy department based on the actual amount of the previous year, combined with the following reference factors, and according to the requirements of the relevant documents of the collection of collection, the calculation results are within a certain proportion. Report after communication.

(1) Use of prediction quantities in the previous year;

(2) The trend of the use of varieties of forecast varieties in the past three years;

(3) Pharmaceutical management policies, the latest progress of new drug research and development and disease diagnosis and treatment, and the impact of emergencies such as new crown epidemic conditions;

(4) Whether the variety of forecast quantities is the basic drug of the country, whether it is the variety in the national basic medical insurance drug catalog, whether the medical insurance payment restrictions are changed, and whether it is the key monitoring variety of this medical institution;

(5) The completion of the forecast variety or other drugs within the previous collection cycle.

It is recommended that the medical institution's medical department refer to the use of drug usage in the previous year and the proportion of medicines in various departments, and combines the actual diagnosis and treatment needs to distribute the amount of drug mission to the main use department. Conditional medical institutions can refine the task quantity and allocate allocation To the doctor group.

Third, use monitoring and control

Medical institutions shall establish a dynamic monitoring mechanism for the use of drugs, and the use of regular (monthly/quarter/year) monitoring and notifying the use of medicines in the same name, the same name of the same name, and alternative drugs in the same type Dynamic adjustment of control measures.

Management and control measures generally include:

(1) Regularly feedback the use of drugs to clinicians;

(2) The information system warns the collection of collection medicines that do not meet the progress;

(3) Limit the procurement and use of the same name non -secondary drug and similar alternative drugs;

(4) Hold the promotion meeting of collection drugs.

Fourth, directory management

After the introduction of collection medicines, in order to facilitate management, it can generally be optimized in accordance with the principle of "one product, two regulations". In special cases, multi -quality medicines can be considered in special cases.

Directory optimization suggestions are as follows:

(1) Reserve reference preparations for selected varieties;

(2) The retaining price is lower than the selection of varieties in the collection and passing consistency evaluation.

For the original selected drugs that have not renewed the contract after the agreement expire, the medical institution can determine whether to keep reserved in accordance with the actual situation according to the actual situation.

5. Supply guarantee

The pharmacy department shall strengthen the protection of drug supply to meet the needs of clinical medication.

(1) Selected medicine

Medical institutions shall be in accordance with the policy requirements [4], ensuring that the purchase volume of drug procurement during the agreement period shall not be less than the same number of drug procurement in the same name. If the original production or distribution enterprise cannot guarantee normal supply, medical institutions should start the emergency supply guarantee mechanism of collecting drugs, increase non -secondary drugs or concentrated band quantities to purchase alternative drugs [7] to reserve and adjust control measures, and report the shortage to the shortage. The superior medical insurance department requested to coordinate.

It is recommended that higher -level medical insurance departments in a timely coordination to solve the problem of shortage of drug supply in China, and reduce the corresponding drug tasks according to the shortage of drugs according to the shortage of drugs, and adjust the number of non -secondary drugs.

(2) Non -selected medicines

On the basis of implementing the drug collection policy, medical institutions should ensure the normal supply of non -secondary drugs in order to meet the different drug needs of patients, while daily monitoring.

6. Reasonable use

Medical institutions should strengthen the review of drug prescriptions (medical order), standardize the prescription (medical order) reviews, establish a feedback improvement mechanism, and improve the level of reasonable medication. Seven, drug quality management and adverse events monitoring

Medical institutions should strengthen the quality and clinical medication management [2,8], and discover adverse reactions or suspected adverse reactions to report in time in time. Conditional medical institutions can use the information system to actively monitor and early warning the adverse reactions of collecting drugs to provide data support for the safety evaluation of drugs. At the same time, medical institutions can feedback the quality and adverse reaction information collected and sorted out of the quality and adverse reactions of the collection of drugs and medical insurance departments.

Eight, assessment and incentive

Medical institutions shall include the use of collection drugs into performance assessment [2,8] to formulate assessment plans to promote reasonable medication and collection tasks.

Medical institutions should use the actual situation in accordance with the policy requirements, combined with their own actual situation, and use the balance of reserved funds for relevant personnel's performance rewards.

Nine, informatization construction

Medical institutions should strengthen informatization construction and achieve refined management of the whole process of collecting and mining. The information system should generally have the following functions:

(1) According to the changes in the batch and hospital's drug directory, the selection of drugs, non -secondary drugs, and similar alternative drugs in the maintenance;

(2) Using informatization methods such as HIS system, reasonable medication software, and prescription pre -review system to set individualized management rules for collection drugs, mark the selected drugs, and do not have the same name non -secondary medicine and similar alternative medicines. To warn the reasonable usage;

(3) Statistical selection of drugs, the same name non -secondary drug, the use of similar alternative drugs, and setting the use permissions.

X. Comprehensive evaluation of drugs clinical

Medical institutions can carry out comprehensive clinical evaluation of pharmaceutical clinical clinical clinical in combined with actual conditions, and provide reference for drug directory management and clinical rational drug use.

Eleven, others

The promotion of this consensus and the promotion of the collection and the adjustment of the collection policy is updated in a timely manner.

Written an expert group

Team leader:

Ma Peizhi

Henan Provincial People's Hospital

Member (sorted by surname strokes):

Ding Zenglin

Luyi County People's Hospital

Ma Peizhi

Henan Provincial People's Hospital

Wang Li

Henan Provincial People's Hospital

King Rui

Luohe Central Hospital

Wang Xiuqing

Anyang People's Hospital

Fang Fengqin

Henan Provincial People's Hospital

Kong Yonghong

Zhumadian Central Hospital

Deng Zhijian

Xinxiang Medical College First Affiliated Hospital

Lu Lijun

Nanyang Medical Higher College First Affiliated Hospital

Lu Xuecheng

Shangqiu First People's Hospital

Liu Rinpin

Xinyang Central Hospital

Sun Baoling

Junxian People's Hospital

Li Xiangping

Jiyuan People's Hospital

Li Junxi

Jiaozuo Coal Industry (Group) Co., Ltd. Central Hospital

Li Junxia

Henan Provincial Chest Hospital

Li Xueyan

Yiyang County Traditional Chinese Medicine Hospital

He Yu

Zhengzhou Central Hospital

Zhang Fenglin

Puyang People's Hospital

Zhang Wenzhou

Henan Cancer Hospital

Zhang Yongzhou

Huaihe Hospital, Henan University

Zhang Shihui

Tancheng County People's Hospital

Society

Qingshan County People's Hospital

Zhang Xiaojian

First Affiliated Hospital of Zhengzhou University

Chen Jun

Luoshan County People's Hospital

Chen Nan

Zhengzhou People's Hospital

Zheng Zhixin

Nanyang Middle Hospital

Zhao Xu

Henan Provincial Hospital

Zhao Liang

Xuchang Central Hospital

Chaling

Zhoukou Middle Hospital

Lou Chaoyu

Henan University of Science and Technology First Affiliated Hospital

Fly high

Sanmenxia Central Hospital

Tang Jinfa

Henan University of Traditional Chinese Medicine First Affiliated Hospital

Recreational

First Affiliated Hospital of Zhengzhou University

Jiao Hongjun

Zhengzhou University Second Affiliated Hospital

Cai Weiwei

General Hospital of Pingmei Shenma Medical Group

Members of writing expert groups (sorted by surnamed strokes):

Wang Li

Henan Provincial People's Hospital

Fang Fengqin

Henan Provincial People's Hospital

Recreational

First Affiliated Hospital of Zhengzhou University

references

[1] Notice of the General Office of the State Council. Notice on printing and issuing the pilot scheme of centralized procurement and use of national organizational drugs (National Office [2019] No. 2).

[2] Henan Provincial Health and Health Committee. Notice on the selection of drug clinical equipment in the centralized procurement of the country (Yu Medicine Pharmaceutical [2019] No. 6).

[3] Henan Provincial Department of Industry and Information Technology, Henan Provincial Department of Henan Province, Henan Provincial Department of Commerce, Henan Provincial Health and Health Committee of Henan Provincial Department of Health and Health, Henan Provincial Market Supervision and Administration Bureau, Henan Provincial Department of Health and Health, Henan Province Notice of the implementation of the implementation plan for centralized procurement of drugs in Henan Province to implement centralized procurement of drugs (Yu Yibao [2019] No. 13).

[4] Henan Provincial Medical Security Bureau. Notice on the implementation of the national organizational drugs to be concentrated in pharmaceutical procurement and use of pilot expansion of medical insurance supporting measures (Yu Medicine Pharmaceutical Letter [2019] No. 53).

[5] The General Office of the State Council. Opinions on promoting the normalization and institutionalization of drugs to promote the purchasing work of centralized bands (Guoqi Fa [2021] No. 2).

[6] Henan Provincial Medical Guarantee Bureau. Notice on the scope of the country and the province's centralized band procurement varieties (Yuyi Insurance [2021] No. 64).

[7] Henan Provincial Medical Security Bureau. Notice on determining the relevant matters related to the selection of alternative drugs (Yu Medical Insurance Office [2022] No. 11). [8] The General Office of the National Health and Health Commission.Notice of Selecting Pharmaceutical Equipment in the centralized procurement (National Health Office Medical Letter [2019] No. 889).

[9] The National Medical Security Bureau of the Ministry of Human Resources and Social Security of the Ministry of Finance of the Ministry of Finance of the National Health and Health Commission.

[10] The Ministry of Finance of the State Medical Security Bureau. Regarding the guidance of the centralized procurement of drugs in the country's organizational procurement (Medical Insurance Fa [2020] No. 26).

[11] Henan Provincial Department of Medical Security, Henan Provincial Department of Finance. Notice on printing and issuing the implementation plan for the collection of medical insurance funds for centralized procurement of medical insurance funds (trial) (Trial) (Yuyi Insurance Office [2021] No. 2).

Source: Henan Pharmaceutical Association

Click the link to download the original text: https://pan.baidu.com/s/1bnv87M67SO6UYIC8FFFFDCW? PWD = RMKFF

- END -